Hangzhou Alltest Biotech Co., Ltd.
Status: Publicly traded
Direct answer
Hangzhou Alltest Biotech Co., Ltd. is publicly traded on SHH under the ticker 688606.SS.
Hangzhou Alltest Biotech Co., Ltd. operates internationally, specializing in the entire process of in vitro diagnostic reagents, from their initial research and development to manufacturing and market distribution. The company supplies a wide array of rapid diagnostic solutions, encompassing crucial health sectors like women's health, infectious disease detection, drug screening, cancer diagnostics, and...
Can you invest in Hangzhou Alltest Biotech Co., Ltd.?
Yes. Hangzhou Alltest Biotech Co., Ltd. trades publicly on SHH as 688606.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hangzhou Alltest Biotech Co., Ltd.
Detailed equity research is provided by MarketSnap.